Academic Journal
Προβολή σε EDS

Addressing Analytical Challenges to Improve Laboratory Consistency in Unbound Flucloxacillin Measurement

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος: Addressing Analytical Challenges to Improve Laboratory Consistency in Unbound Flucloxacillin Measurement
Συγγραφείς: Van herteryck, Cathérine, Reyns, Tim, Jager, Nynke, Stove, Veronique, Verougstraete, Nick
Πηγή: Therapeutic Drug Monitoring ; ISSN 0163-4356 1536-3694
Στοιχεία εκδότη: Ovid Technologies (Wolters Kluwer Health)
Έτος έκδοσης: 2026
Περιγραφή: Background: Accurate quantification of flucloxacillin (FLU) in plasma is essential for therapeutic drug monitoring (TDM). Although TDM of FLU traditionally targets total concentrations, only the unbound drug is pharmacologically active. Ultrafiltration (UF) enables the separation of the unbound drug; however, multiple pre-analytical variables can affect results. Furthermore, the lack of standardized protocols currently limits interlaboratory reproducibility. This study aims to develop and validate a robust liquid chromatography-high-resolution mass spectrometric (LC-HRMS) method for quantifying unbound FLU, including an extensive assessment of analyte stability. Cross-validation with an external laboratory was performed to support harmonization of UF protocols. Methods: Ultrafiltrate was obtained after incubation (10 minutes at 37°C) and UF (30 minutes at 1900 g and 37°C), and analyzed using LC-HRMS. Analytical and pre-analytical protocols were validated in accordance with European Medicine Agency guidelines, evaluating calibration curves, selectivity, carryover, accuracy, precision, matrix effect, stability, dilution integrity, as well as nonspecific binding, and membrane protein leakage. Cross-validation was conducted using patient samples from clinical routine. Results: The method validation was successful. Ultrafiltrate stability was substantially lower than plasma stability, emphasizing the need for immediate postfiltration analysis. Interlaboratory comparison demonstrated strong concordance, with >90% of samples differing by <±25.0%. Conclusions: A validated LC-HRMS method for quantifying unbound FLU was developed using UF. Cross-validation showed that comparable results can be achieved across laboratories when key UF parameters, such as device type and temperature, are harmonized. Because of the limited stability of FLU in ultrafiltrate, sample storage in plasma matrix is recommended.
Τύπος εγγράφου: article in journal/newspaper
Γλώσσα: English
DOI: 10.1097/ftd.0000000000001449
DOI: 10.1097/FTD.0000000000001449
Διαθεσιμότητα: https://doi.org/10.1097/ftd.0000000000001449
https://journals.lww.com/10.1097/FTD.0000000000001449
Αριθμός Καταχώρησης: edsbas.F8FDBC94
Βάση Δεδομένων: BASE
FullText Text:
  Availability: 0
CustomLinks:
  – Url: https://doi.org/10.1097/ftd.0000000000001449#
    Name: EDS - BASE (ns324271)
    Category: fullText
    Text: View record from BASE
Header DbId: edsbas
DbLabel: BASE
An: edsbas.F8FDBC94
RelevancyScore: 941
AccessLevel: 3
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 940.635681152344
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Addressing Analytical Challenges to Improve Laboratory Consistency in Unbound Flucloxacillin Measurement
– Name: Author
  Label: Authors
  Group: Au
  Data: &lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Van+herteryck%2C+Cath&#233;rine%22&quot;&gt;Van herteryck, Cath&#233;rine&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Reyns%2C+Tim%22&quot;&gt;Reyns, Tim&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Jager%2C+Nynke%22&quot;&gt;Jager, Nynke&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Stove%2C+Veronique%22&quot;&gt;Stove, Veronique&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Verougstraete%2C+Nick%22&quot;&gt;Verougstraete, Nick&lt;/searchLink&gt;
– Name: TitleSource
  Label: Source
  Group: Src
  Data: Therapeutic Drug Monitoring ; ISSN 0163-4356 1536-3694
– Name: Publisher
  Label: Publisher Information
  Group: PubInfo
  Data: Ovid Technologies (Wolters Kluwer Health)
– Name: DatePubCY
  Label: Publication Year
  Group: Date
  Data: 2026
– Name: Abstract
  Label: Description
  Group: Ab
  Data: Background: Accurate quantification of flucloxacillin (FLU) in plasma is essential for therapeutic drug monitoring (TDM). Although TDM of FLU traditionally targets total concentrations, only the unbound drug is pharmacologically active. Ultrafiltration (UF) enables the separation of the unbound drug; however, multiple pre-analytical variables can affect results. Furthermore, the lack of standardized protocols currently limits interlaboratory reproducibility. This study aims to develop and validate a robust liquid chromatography-high-resolution mass spectrometric (LC-HRMS) method for quantifying unbound FLU, including an extensive assessment of analyte stability. Cross-validation with an external laboratory was performed to support harmonization of UF protocols. Methods: Ultrafiltrate was obtained after incubation (10 minutes at 37&#176;C) and UF (30 minutes at 1900 g and 37&#176;C), and analyzed using LC-HRMS. Analytical and pre-analytical protocols were validated in accordance with European Medicine Agency guidelines, evaluating calibration curves, selectivity, carryover, accuracy, precision, matrix effect, stability, dilution integrity, as well as nonspecific binding, and membrane protein leakage. Cross-validation was conducted using patient samples from clinical routine. Results: The method validation was successful. Ultrafiltrate stability was substantially lower than plasma stability, emphasizing the need for immediate postfiltration analysis. Interlaboratory comparison demonstrated strong concordance, with &gt;90% of samples differing by &lt;&#177;25.0%. Conclusions: A validated LC-HRMS method for quantifying unbound FLU was developed using UF. Cross-validation showed that comparable results can be achieved across laboratories when key UF parameters, such as device type and temperature, are harmonized. Because of the limited stability of FLU in ultrafiltrate, sample storage in plasma matrix is recommended.
– Name: TypeDocument
  Label: Document Type
  Group: TypDoc
  Data: article in journal/newspaper
– Name: Language
  Label: Language
  Group: Lang
  Data: English
– Name: DOI
  Label: DOI
  Group: ID
  Data: 10.1097/ftd.0000000000001449
– Name: DOI
  Label: DOI
  Group: ID
  Data: 10.1097/FTD.0000000000001449
– Name: URL
  Label: Availability
  Group: URL
  Data: https://doi.org/10.1097/ftd.0000000000001449&lt;br /&gt;https://journals.lww.com/10.1097/FTD.0000000000001449
– Name: AN
  Label: Accession Number
  Group: ID
  Data: edsbas.F8FDBC94
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edsbas&AN=edsbas.F8FDBC94
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1097/ftd.0000000000001449
    Languages:
      – Text: English
    Titles:
      – TitleFull: Addressing Analytical Challenges to Improve Laboratory Consistency in Unbound Flucloxacillin Measurement
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Van herteryck, Cathérine
      – PersonEntity:
          Name:
            NameFull: Reyns, Tim
      – PersonEntity:
          Name:
            NameFull: Jager, Nynke
      – PersonEntity:
          Name:
            NameFull: Stove, Veronique
      – PersonEntity:
          Name:
            NameFull: Verougstraete, Nick
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-locals
              Value: edsbas
          Titles:
            – TitleFull: Therapeutic Drug Monitoring ; ISSN 0163-4356 1536-3694
              Type: main
ResultId 1